Medline ® Abstract for Reference 50
of 'Epidemiology, risk factors and the clinical approach to ER/PR negative, HER2-negative (Triple-negative) breast cancer'
Should a biopsy be recommended to confirm metastatic disease in women with breast cancer?
Amir E, Clemons M
Lancet Oncol. 2009;10(10):933.